Elevance stock rating reiterated at Overweight by Cantor Fitzgerald

Investing.comTuesday, September 16, 2025 at 12:11:05 PM
Elevance stock rating reiterated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald has reiterated its Overweight rating on Elevance stock, indicating confidence in the company's performance and potential for growth.
Editor’s Note: This rating is significant as it reflects analysts' positive outlook on Elevance, which could influence investor decisions and market trends.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Bo Hines To Lead Tether's New US Stablecoin USAT
PositiveFinancial Markets
Tether Holdings SA is set to launch a US-regulated stablecoin called USAT in collaboration with Cantor Fitzgerald LP and Anchorage Digital Bank NA. This initiative aims to comply with the Genius Act.
Editor’s Note: The introduction of USAT is significant as it represents a step towards regulatory compliance in the cryptocurrency space, potentially increasing trust and adoption among users and investors.
Tenet Healthcare stock rating reiterated by Cantor Fitzgerald amid 2026 Marketplace uncertainty
NeutralFinancial Markets
Cantor Fitzgerald has reiterated its stock rating for Tenet Healthcare, despite uncertainties surrounding the 2026 marketplace. This decision reflects the firm's confidence in Tenet's long-term prospects.
Editor’s Note: This matters because stock ratings can significantly influence investor confidence and market performance. Tenet Healthcare operates in a critical sector, and understanding its stock outlook helps investors make informed decisions.
UnitedHealth stock rating reiterated at Overweight by Cantor Fitzgerald
PositiveFinancial Markets
Cantor Fitzgerald has reiterated its Overweight rating on UnitedHealth stock, indicating confidence in the company's performance and growth potential.
Editor’s Note: This rating is significant as it reflects analysts' positive outlook on UnitedHealth, which could influence investor decisions and market trends in the healthcare sector.
Cigna stock rating reiterated at Overweight by Cantor Fitzgerald
PositiveFinancial Markets
Cantor Fitzgerald has reiterated its Overweight rating on Cigna's stock, indicating confidence in the company's performance and potential for growth.
Editor’s Note: This rating is significant as it reflects analysts' positive outlook on Cigna, suggesting that investors may consider it a strong investment opportunity.
Cantor Fitzgerald reiterates Axsome Therapeutics stock rating, maintains price target
PositiveFinancial Markets
Cantor Fitzgerald has reaffirmed its stock rating for Axsome Therapeutics and is maintaining its price target, indicating confidence in the company's future performance.
Editor’s Note: This is significant for investors as it reflects the analysts' belief in Axsome Therapeutics' potential growth and stability in the market, which can influence investment decisions.
Centene stock rating maintained by Cantor Fitzgerald amid marketplace rate concerns
NeutralFinancial Markets
Cantor Fitzgerald has maintained its stock rating for Centene despite concerns regarding marketplace rates. This decision reflects confidence in Centene's performance amid market fluctuations.
Editor’s Note: Maintaining a stock rating can influence investor confidence and market perception. Cantor Fitzgerald's stance on Centene suggests they believe the company will navigate current challenges effectively, which is important for stakeholders.
JFrog stock price target raised to $60 from $55 at Cantor Fitzgerald
PositiveFinancial Markets
Cantor Fitzgerald has raised its stock price target for JFrog from $55 to $60, indicating a positive outlook for the company.
Editor’s Note: This increase in the stock price target suggests that analysts are optimistic about JFrog's future performance, which could attract more investors and boost market confidence.
Cantor Fitzgerald downgrades aTyr Pharma stock rating on failed trial
NegativeFinancial Markets
Cantor Fitzgerald has downgraded the stock rating of aTyr Pharma following the disappointing results of a recent clinical trial. This decision reflects concerns about the company's future prospects.
Editor’s Note: This downgrade is significant as it may impact investor confidence and the stock's market performance. Clinical trial results are crucial for biotech companies, and a negative outcome can lead to decreased funding and support.
Cantor Fitzgerald assumes coverage on Adani Green Energy stock with Overweight rating
PositiveFinancial Markets
Cantor Fitzgerald has initiated coverage on Adani Green Energy, giving it an Overweight rating. This suggests a positive outlook for the company's stock performance.
Editor’s Note: This matters because an Overweight rating indicates that analysts expect Adani Green Energy to outperform its peers, which could attract more investors and boost the company's market presence.
Latest from Financial Markets
Infamous Fyre Festival Sells for Fire-Sale Price of $245,000
NegativeFinancial Markets
The Fyre Festival brand has been sold for $245,000 after failing to launch a follow-up event. LimeWire, a file-sharing company, is the new owner.
Trump Delays TikTok Ban Again
NeutralFinancial Markets
Former President Donald Trump has postponed the ban on TikTok once again, allowing the app to continue operating in the U.S. This decision comes amid ongoing discussions about data privacy and national security.
Editor’s Note: This matters because the TikTok ban has been a contentious issue, raising concerns about user data and foreign influence. Trump's delay indicates that the debate over the app's future is still very much alive.
Federal Reserve to Meet Under Cloud of Trump’s Attacks
NeutralFinancial Markets
The Federal Reserve is set to meet on Wednesday, with Stephen Miran and Lisa Cook voting on potential interest rate cuts amid ongoing criticism from Trump.
Editor’s Note: This meeting is significant as it could influence the economy and financial markets. The Fed's decisions on interest rates are closely watched, especially in the context of political pressures.
Carney to Unveil Budget Nov. 4 as ‘Substantial’ Deficit Expected
NeutralFinancial Markets
Canada's federal budget will be unveiled on November 4, as a significant deficit is anticipated, according to Finance Minister Francois-Philippe Champagne.
Editor’s Note: This budget announcement is crucial as it will outline the government's financial plans and address the expected deficit, impacting economic policies and public services.
Cook, Miran Present as Fed Meets to Consider Cutting Rates
NeutralFinancial Markets
Kitty Richards from the Groundwork Collaborative discusses recent economic data as the Federal Reserve considers cutting interest rates.
Editor’s Note: This meeting is significant as it could impact borrowing costs and economic growth. Understanding the Fed's decisions helps us gauge the future of the economy.
EPA Proposes Large Refineries Offset Waived Biofuel Quotas
NeutralFinancial Markets
The US government has proposed measures for large refineries to offset biofuel blending requirements that were waived for smaller oil processors. This aims to balance the biofuel market.
Editor’s Note: This proposal is significant as it addresses the ongoing challenges in the biofuel sector, ensuring that large refineries contribute to blending requirements, which could impact fuel prices and environmental policies.